BBHC
GBT

Brown Brothers Harriman & Co’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Brown Brothers Harriman & Co’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,300
Closed -$81 – 1243
2021
Q2 		$81 Sell
2,300
-350
-13% -$13.7K ﹤0.01% 590
2021
Q1 		$108 Sell
2,650
-300
-10% -$13.8K ﹤0.01% 506
2020
Q4 		$128K Buy
+2,950
New +$145K ﹤0.01% 515

Other funds holding GBT

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Brown Brothers Harriman & Co's GBT Position: Q3 2021 in Review

Brown Brothers Harriman & Co sold out of Global Blood Therapeutics, Inc. (GBT) in Q3 2021, closing a stake of 2,300 shares — an estimated $81 sold.

Brown Brothers Harriman & Co first reported a position in GBT in Q4 2020 and held it in 3 quarters. The position peaked at $128K in Q4 2020. 187 funds tracked by Wall St. Rank hold GBT as of Q3 2021.

  • Brown Brothers Harriman & Co reported no remaining Global Blood Therapeutics, Inc. position as of Q3 2021 after selling out during the quarter.
  • Brown Brothers Harriman & Co sold 2,300 Global Blood Therapeutics, Inc. shares in Q3 2021, an estimated $81.
  • Brown Brothers Harriman & Co first reported a position in Global Blood Therapeutics, Inc. in Q4 2020 and held it in 3 quarters.
  • Brown Brothers Harriman & Co's Global Blood Therapeutics, Inc. position peaked at $128K in Q4 2020.
  • 187 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q3 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2021, filed 15 Nov 2021.